DePuy Synthes launches knee arthroscopy device

15 May 2018 (Last Updated May 15th, 2018 14:28)

DePuy Synthes has unveiled a knee arthroscopy solution called TRUESPAN Meniscal Repair System as part of its Mitek Sports Medicine portfolio. 

DePuy Synthes has unveiled a knee arthroscopy solution called TRUESPAN Meniscal Repair System as part of its Mitek Sports Medicine portfolio.

The new device is developed to facilitate simple and reproducible meniscal repair during arthroscopy surgeries in Europe, the Middle East, and Africa. It is intended to further enhance operating room efficiency.

TRUESPAN has been designed as a delivery system that features an ergonomic handle, single trigger, and auto-reloading to allow fast, simple one-handed use.

The system protects implants and sutures against jamming or misfiring with a depth-stop and rigid needle, which is available in 0°, 12° and 24° variants with non-absorbable PEEK implants.

DePuy Synthes EMEA Joint Reconstruction vice-president Torbjorn Sköld said: “We are excited to offer the TRUESPAN all-inside meniscal repair device to our customers to support them in their delivery of reproducible procedures and improved operating room efficiencies.”

“The system protects implants and sutures against jamming or misfiring with a depth stop and rigid needle.”

DePuy Synthes also entered an agreement to buy the assets of surgical impactor technology developer, Medical Enterprises Distribution.

Financial details of the acquisition have not been disclosed. The deal is in part of DePuy’s strategy to transform orthopaedic surgery through a comprehensive digital surgery platform.

Medical Enterprises Distribution’s portfolio includes a battery-powered ME1000 Surgical Impactor device designed to automate bone preparation, implant assembly and positioning in total hip arthroplasty (THA).

The device can be used with different surgical procedures and is compatible with certain DePuy Synthes implants such as ACTIS Total Hip System developed for the anterior approach.

DePuy intends to further develop and expand the surgical impactor technology for various orthopaedic surgery procedures.

The transaction is subject to customary closing conditions, which is expected to complete over the coming months.